Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist II / Sr. Scientist I, Toxicology - Pharmacology, Pharmacological Sciences

Employer
BioMarin Pharmaceutical Inc.
Location
San Rafael, CA, United States
Start date
Feb 28, 2019

View more

Job Details

Scientist II / Sr Scientist, Toxicologist / Pharmacologist BioMarin's Pharmacological Sciences Team

The Pharmacology and Toxicology Department at BioMarin is seeking a Scientist (Scientist 2 to Senior Scientist 2 depending on experience) to provide toxicology and pharmacology expertise for the development of BioMarin's novel drug candidates. This individual will provide scientific leadership and play a pivotal role in support of all phases of drug development from discovery through clinical trials, market application and commercialization. Each BioMarin scientist has the opportunity and is expected to actively contribute to the discovery and development of life-transforming drugs. The successful candidate will be responsible for designing and overseeing the execution of non-clinical studies that evaluate the safety and/or efficacy of drug candidates, including pivotal studies to enable first-in-human clinical trials. This individual will work collaboratively with internal and external cross-functional teams, and consultants to support the successful and timely advancement of drug-development programs. Additional responsibilities include presenting data and be an active member on cross-functional project teams and/or lead project sub-teams.

A strong toxicology and pharmacology background as well as an understanding of mechanisms of disease will be required to provide broad-based support for the company's opportunistic philosophy of drug development. Key to the role, is the ability to analyze and interpret complex data to help elucidate the toxicological and pharmacological profile of drug candidates. S/he will need to communicate data, findings and interpretations both in oral and written form. The candidate will deliver a balanced assessment of the risk/benefit profile associated with a drug candidate, bridging across studies and animal species.

RESPONSIBILITIES

Design and implement a nonclinical and clinical toxicology strategy to support drug development at all stages. Analyze and interpret nonclinical data to support the progression of gene, cell or enzyme replacement therapies. Author and/or review study protocols, study reports and regulatory submission documents. Interact and collaborate with various BioMarin functions, CROs, universities, analytical laboratories, business partners, as necessary to ensure appropriate/timely progression of BioMarin projects. Participate in multi-disciplinary drug-development teams.

EDUCATION:

Required: Doctorate (Ph.D.) in pharmacology, toxicology or a related relevant field. DABT certification is desirable.

EXPERIENCE:

Toxicology/pharmacology background with 4-7 years of experience working in biopharmaceutical industry. Experience supporting rare disease indications is desirable. Experience working with biologics, small molecules and/or gene therapy. Designing and implementing the non-clinical strategy for drug-development programs, and interpreting GLP and non-GLP nonclinical pharmacology and toxicology studies. Expertise in in vivo and in vitro pharmacology and/or experience with animal models of disease. Understanding drug development and regulatory processes, as well as Good Laboratory Practices (GLPs). Drafting regulatory submission documents.

SKILLS:

Strong data analysis and data interpretation skills. Strong statistical analysis and bioinformatics capabilities. Strong critical, scientific, and strategic thinking skills. Strong problem solving and decision making abilities. Strong communication (verbal and written) skills. Ability to meet aggressive time-lines. Ability to build/foster productive cross-functional collaborations both within and outside BioMarin.

~BIO

Company

BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
Website
Location
California
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert